Last Updated 1 July 2022.
11 Vaccines Approved for Use in Indonesia
-
Anhui Zhifei Longcom
Zifivax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
20 trials in 5 countries
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 5 countries
3 trials in 1 country
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
67 trials in 23 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
85 trials in 27 countries
-
CanSino
Convidecia- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 10 countries
13 trials in 6 countries
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
25 trials in 8 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
24 trials in 24 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
66 trials in 31 countries
-
Shenzhen Kangtai Biological Products Co
KCONVAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
7 trials in 1 country
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 91 countries
31 trials in 13 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
37 trials in 9 countries
13 Vaccines in Clinical Trials in Indonesia
-
Anhui Zhifei Longcom
Zifivax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
20 trials in 5 countries
-
PT Bio Farma
SARS-CoV-2 Protein Subunit Recombinant Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
West China Hospital
Recombinant (Sf9 cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 4 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
67 trials in 23 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
85 trials in 27 countries
-
Walvax
mRNA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 3 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
66 trials in 31 countries
-
ReiThera
GRAd-COV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 12 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
37 trials in 9 countries
-
Adimmune Corporation
AdimrSC-2f- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 2 countries
-
Aivita Biomedical Inc
AV-COVID-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries
-
Airlangga University
UNAIR Inactivated COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
PT Bio Farma
SARS-CoV-2 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country